BIOLARGO, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOLARGO, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-09-30 was $600.00K, a 75.05% decline year-over-year.
- BIOLARGO, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-06-30 was $328.00K, a 52.33% decline year-over-year.
- BIOLARGO, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-09-30 was $2.40M, a 510.41% increase year-over-year.
- BIOLARGO, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-06-30 was $688.00K, a 132.43% increase year-over-year.
- BIOLARGO, INC. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $328.00K, a 90.70% decline from fiscal 2020.
- BIOLARGO, INC. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $3.53M, a 103.23% increase from fiscal 2019.
- BIOLARGO, INC. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $1.74M, a 71.97% decline from fiscal 2018.
- BIOLARGO, INC. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $6.19M, a 593.95% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2021-12-31 | $328.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $600.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $328.00K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $3.53M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $2.40M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $688.00K 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $434.00K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $1.74M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $394.00K 10-Q · filed 2020-11-16 | $536.54K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $296.00K 10-Q · filed 2020-11-16 | $476.54K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-03-31 | $219.00K 10-Q · filed 2020-11-16 | $6.41M derived: sum of 4 quarters · filed 2020-11-16 |
| 2018-12-31 | -$372.46K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | $6.19M 10-K · filed 2020-03-31 |
| 2018-09-30 | $334.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $6.23M 10-Q · filed 2019-11-14 | |
| 2017-12-31 | $55.75K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $892.00K 10-K · filed 2019-03-29 |
| 2017-09-30 | $306.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $1.07M derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-06-30 | $130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | |
| 2017-03-31 | $400.00K 10-Q · filed 2017-05-17 | |
| 2016-12-31 | $236.81K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $589.37K 10-K · filed 2018-03-16 |
| 2015-12-31 | $64.56K 10-K · filed 2017-03-30 | |
| 2014-12-31 | $584.80K 10-K · filed 2016-03-30 |